Pharmabiz15m
AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC
AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...
Pharmabiz1h
Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury
Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury: Toronto Wednesday, November 13, 2024, 1 ...
Pharmabiz2h
Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative (MTM Vision) jointly announce the start of a long-term collaboration as Boehringer becomes the first pharmaceutical company to join the ...
Pharmabiz3h
AstraZeneca to invest $3.5 billion in R&D and manufacturing in US
AstraZeneca to invest $3.5 billion in R&D and manufacturing in US: Cambridge, UK Wednesday, November 13, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science-led biopharmaceutical ...
Pharmabiz4h
Inter-ministerial committee calls for amendment in FSSAI Act on nutraceuticals
Inter-ministerial committee calls for amendment in FSSAI Act on nutraceuticals: Gireesh Babu, New Delhi Wednesday, November 13, 2024, 08:00 Hrs [IST] An inter-ministerial committe ...
Pharmabiz4h
Indian pharma stresses for enhanced fire safety measures and improved insurance coverage for employees
Indian pharma stresses for enhanced fire safety measures and improved insurance coverage for employees: Nandita Vijayasimha, Bengaluru Wednesday, November 13, 2024, 08:00 Hrs [IST ...
Pharmabiz4h
NABL announces joint technical training programme with MANTRA on medical textiles testing
NABL announces joint technical training programme with MANTRA on medical textiles testing: Shardul Nautiyal, Mumbai Wednesday, November 13, 2024, 08:00 Hrs [IST] The National Accr ...
Pharmabiz4h
Industry hails DoP's new scheme for strengthening of medical devices industry
Industry hails DoP's new scheme for strengthening of medical devices industry: Our Bureau, New Delhi Wednesday, November 13, 2024, 08:00 Hrs [IST] The centrally sponsored scheme f ...
Pharmabiz4h
THE UNHOLY PARTNERSHIP FOR RAPID DRUG DELIVERY
The All India Organization of Chemists and Druggists (AIOCD) has recently expressed concern over the partnership between Swiggy Instamart and PharmEasy for a rapid drug delivery model in the country.
Pharmabiz13h
ALIGNMT AI & HFMA collaborate to offer AI governance micro-credentialing for healthcare professionals
ALIGNMT AI, a leading provider of software solutions for AI governance and compliance, announced a strategic collaboration with the Healthcare Financial Management Association (HFMA) to launch a ...
Pharmabiz14h
STEERLife & Callidus Research Laboratories forge strategic partnership to accelerate innovative drug development
STEERLife, a pioneer in pharmaceutical development technologies, and Callidus Research Laboratories, a formulation development services company with a wealth of experience in comprehensive ...
Pharmabiz14h
ViiV Healthcare deepens its commitment to under-served LGBTI communities, pledging $7.8million in new funding
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced it is pledging $7.8 million to the ‘Fund our Futures’ campaign led by ...